[HTML][HTML] 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American …

DO Kleindorfer, A Towfighi, S Chaturvedi, KM Cockroft… - Stroke, 2021 - journals.lww.com
1. Specific recommendations for prevention strategies often depend on the ischemic
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …

Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment

J Gutierrez, TN Turan, BL Hoh… - The Lancet Neurology, 2022 - thelancet.com
Intracranial atherosclerotic stenosis (ICAS) is one of the most frequent causes of stroke
worldwide and confers one of the greatest risks of recurrent stroke compared with other …

Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart …

WN Kernan, B Ovbiagele, HR Black, DM Bravata… - Stroke, 2014 - Am Heart Assoc
The aim of this updated guideline is to provide comprehensive and timely evidence-based
recommendations on the prevention of future stroke among survivors of ischemic stroke or …

Stroke caused by atherosclerosis of the major intracranial arteries

C Banerjee, MI Chimowitz - Circulation research, 2017 - Am Heart Assoc
Our goal in this review is to discuss the pathophysiology, diagnosis, and treatment of stroke
caused by atherosclerosis of the major intracranial arteries. References for the review were …

Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier

PB Gorelick, KS Wong, HJ Bae, DK Pandey - Stroke, 2008 - Am Heart Assoc
Background and Purpose—Large artery intracranial occlusive disease (LAICOD) is a
common and important stroke subtype. In this commentary, we review key epidemiological …

Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment

CA Holmstedt, TN Turan, MI Chimowitz - The Lancet Neurology, 2013 - thelancet.com
Intracranial atherosclerosis is one of the most common causes of stroke worldwide and is
associated with a high risk of recurrent stroke. New therapeutic approaches to treat this high …

Global burden of intracranial atherosclerosis

LKS Wong - International journal of stroke, 2006 - journals.sagepub.com
Global Burden of Intracranial Atherosclerosis - Lawrence KS Wong, 2006 Skip to main content
Intended for healthcare professionals Sage Journals Home Search this journal Search all …

Intracranial atherosclerosis

AI Qureshi, LR Caplan - The Lancet, 2014 - thelancet.com
Atherosclerotic disease often involves the intracranial arteries including those encased by
cranial bones and dura, and those located in the subarachnoid space. Age, hypertension …

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial

Y Shinohara, Y Katayama, S Uchiyama… - The Lancet …, 2010 - thelancet.com
Background The antiplatelet drug cilostazol is efficacious for prevention of stroke recurrence
compared with placebo. We designed the second Cilostazol Stroke Prevention Study (CSPS …

ACCF/AHA clopidogrel clinical alert: approaches to the FDA “Boxed Warning” a report of the american college of cardiology foundation task force on clinical expert …

Writing Committee Members, DR Holmes Jr… - Circulation, 2010 - Am Heart Assoc
ciation (AHA) convened a writing committee. The ACCF and AHA adhere to a rigorous policy
regarding relationships with industry and other entities (RWI) of authors and peer reviewers …